Excess cancers among HIV-infected people in the United States.
about
HIV, Aging, and Viral Coinfections: Taking the Long View.Risk Of Colorectal Cancer And Associated Mortality In Hiv: A Systematic Review And Meta-Analysis.Long-term nitrite inhalant exposure and cancer risk in MSM.Single-institutional experience of clinicopathological analysis and treatment for lung cancer patients with human immunodeficiency virus infection.Multiple cause-of-death data among people with AIDS in Italy: a nationwide cross-sectional study.Evolving epidemiology of HIV-associated malignancies.HAART and lungs: do HIV protease inhibitors impact cancer risk?Leveraging Cancer Therapeutics for the HIV Cure Agenda: Current Status and Future DirectionsThe predictive role of NLR and PLR for solid non-AIDS defining cancer incidence in HIV-infected subjects: a MASTER cohort study.Malignancies, Particularly B-Cell Lymphomas, Are a Frequent Cause of Mortality in Human Immunodeficiency Virus-1 Patients Despite Highly Active Antiretroviral TherapyCancers attributable to infections among adults with HIV in the United States.Herpes Zoster and Risk of Cancer in the Elderly U.S. Population.Cancer prevention in HIV-infected populations.Risk of Cancer among Commercially Insured HIV-Infected Adults on Antiretroviral Therapy.Role of Natural Killer Cells in HIV-Associated Malignancies.T cell receptor repertoire usage in cancer as a surrogate marker for immune responses.Cervical cancer incidence after up to 20 years of observation among women with HIV.Combining immunotherapy and anticancer agents: the right path to achieve cancer cure?Deaths Due to Screenable Cancers Among People Living With HIV Infection, Florida, 2000-2014.Excess Mortality among HIV-Infected Individuals with Cancer in the United States.Astrocyte Elevated Gene-1 (AEG-1) and the A(E)Ging HIV/AIDS-HAND.The therapeutic and diagnostic potential of the prostate specific membrane antigen/glutamate carboxypeptidase II (PSMA/GCPII) in cancer and neurological diseaseProject ACCRUE: Exploring Options to Increase Awareness of AIDS Malignancy Consortium Clinical Trials in North Carolina.Seroprevalence of Kaposi's sarcoma-associated herpesvirus among HIV-infected Uygurs in Xinjiang, China.Kaposi sarcoma-associated herpesvirus: immunobiology, oncogenesis, and therapy.Lung cancer in persons with HIV.Prevalence of Anal HPV and Anal Dysplasia in HIV-Infected Women From Johannesburg, South Africa.Human Immunodeficiency Virus/AIDS, Human Papillomavirus, and Anal Cancer.Screening for Cancer in Persons Living with HIV Infection.HIV Infection, Immunosuppression, and Age at Diagnosis of Non-AIDS-Defining Cancers.Trends in the incidence of AIDS-defining and non-AIDS-defining cancers in people living with AIDS: a population-based study from São Paulo, Brazil.Oral shedding of herpesviruses in HIV-infected patients with varying degrees of immune status.Racial differences in prostate cancer risk in young HIV-positive and HIV-negative men: a prospective cohort study.Association of CD4+ T-cell Count, HIV-1 RNA Viral Load, and Antiretroviral Therapy With Kaposi Sarcoma Risk Among HIV-infected Persons in the United States and Canada.Human papillomavirus 16 (HPV16) and HPV52 E6-specific immunity in HIV-infected adults on combination antiretroviral therapy.Human papillomavirus-related oropharyngeal cancer in the HIV-infected population.A multi-institutional study of clinicopathological features and molecular epidemiology of epidermal growth factor receptor mutations in lung cancer patients living with human immunodeficiency virus infection.Human papillomavirus-associated cutaneous disease burden in human immunodeficiency virus (HIV)-positive patients: the role of human papillomavirus vaccination and a review of the literature.Cancer burden attributable to cigarette smoking among HIV-infected people in North America.Cervical cancer screening intervals and management for women living with HIV: a risk benchmarking approach.
P2860
Q30245486-4A003EEA-EEE1-4D92-BF7C-07DE55BC0E44Q30491585-6EC793C6-7949-4AEF-9418-19F4F10820D6Q33631041-68F4BADF-4198-4FBC-A724-CCC4E67AA17FQ33684235-371AAFFB-B870-4FEA-9AC0-6E6FAE85F04FQ33706218-B33FD3FF-DC01-48AC-9203-5E51C118EBE6Q34679292-C881DF7E-39F8-4008-8181-40ED0A721676Q35825813-85E812EF-8F3F-41C1-974F-0932F048BD34Q36030989-7A2FBCBD-7976-4371-AB43-7DC7485D88BBQ36120745-AE63338E-C99B-4CED-8413-6EC44493542EQ36241641-92326959-7EE3-45EA-9AF8-3ED8A19290F2Q36259445-11FA2DCC-1B4F-499F-980E-A7592B5C3D4CQ36463623-8236B6F2-F8ED-475D-A704-A51AA72F39C6Q36680086-EEE9CA3F-132D-48E2-B1D2-9761E13EF046Q37416478-A11871D8-40DD-404E-AF7F-4899362B134BQ37712593-11F1757B-A405-4DA8-B3DF-D8A5FECAB189Q38376433-545D3CD0-FE27-41C5-A463-0D2891393982Q38400222-0192DA56-CEEF-4476-A4E3-34B7B1FFF394Q38447992-ACF102D2-C307-4803-B33E-15A6FB8BC8C2Q38656803-16806F89-242F-416B-9AC4-8DC72EFD55BFQ38723336-0740D711-81D2-469D-B16D-B3AF1FF4771BQ38811225-DBB45916-F0B5-495D-80F4-378EF12DB495Q38831232-E7B2AC1E-905A-4139-9B53-276C8B6C79ECQ38831450-D4631756-355E-4ED1-A623-311BCBD722E2Q38933905-7A126CB2-C3AD-49D3-AEE2-A915ADF35392Q38943741-B99BCB32-0888-442D-ACBD-239FC15BF25BQ38949456-DFE7A456-E3DC-4B62-BE3D-D2B716819AA6Q38988920-A5E7CE30-A283-43D6-A776-45DB1950E115Q39020800-764DCA0E-A3B3-4965-9332-4728EE0621B6Q39021760-D14111C0-5D9C-4C9C-B94D-86F9BEB04AA3Q39111243-609C212D-F222-492F-A155-37C535B1D457Q39508906-77A696EC-E03D-408D-8BE3-3EEBA7C3D69CQ40116637-200B72A7-BD6F-4E79-B132-E155874251E4Q40223990-E83DE5AC-F645-41D8-96D5-F299699BA91FQ40250347-AD227A45-B34C-4449-B6B1-F557C11C3776Q40533645-07E39D69-8297-4521-8702-BCBE620FFA5AQ40701232-0ECCE6A0-4ADA-4380-A330-9ADA04AF7965Q41393034-1E4192B0-10DD-43B1-88FA-50F608EA53DEQ45324643-9295F5D7-E329-418C-A5CB-2D5BD8F2B6A3Q45981767-C8A585E0-465A-4686-8A46-06EC9CB5789FQ46335294-D11BE038-35F8-415D-B313-6956CA7CF00C
P2860
Excess cancers among HIV-infected people in the United States.
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Excess cancers among HIV-infected people in the United States.
@ast
Excess cancers among HIV-infected people in the United States.
@en
type
label
Excess cancers among HIV-infected people in the United States.
@ast
Excess cancers among HIV-infected people in the United States.
@en
prefLabel
Excess cancers among HIV-infected people in the United States.
@ast
Excess cancers among HIV-infected people in the United States.
@en
P2093
P2860
P356
P1476
Excess cancers among HIV-infected people in the United States.
@en
P2093
Eric A Engels
H Irene Hall
Hilary A Robbins
Jianmin Li
Meredith S Shiels
Ruth M Pfeiffer
P2860
P356
10.1093/JNCI/DJU503
P407
P577
2015-02-06T00:00:00Z